Identification of heparin affin regulatory peptide domains with potential role on angiogenesis
- 1 April 2004
- journal article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 36 (10) , 1954-1966
- https://doi.org/10.1016/j.biocel.2004.02.012
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Dominant Negative Effectors of Heparin Affin Regulatory Peptide (HARP) Angiogenic and Transforming ActivitiesPublished by Elsevier ,2002
- Pleiotrophin: A Cytokine with Diverse Functions and a Novel Signaling PathwayArchives of Biochemistry and Biophysics, 2002
- Endogenous angiogenesis inhibitors and their therapeutic implicationsThe International Journal of Biochemistry & Cell Biology, 2001
- The Lysine-rich C-terminal Tail of Heparin Affin Regulatory Peptide Is Required for Mitogenic and Tumor Formation ActivitiesPublished by Elsevier ,2001
- Glycosaminoglycans Promote HARP/PTN DimerizationBiochemical and Biophysical Research Communications, 1999
- Transformation by Ras Suppresses Expression of the Neurotrophic Growth Factor PleiotrophinPublished by Elsevier ,1997
- Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophinProceedings of the National Academy of Sciences, 1996
- Effect of herparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptideJournal of Cellular Physiology, 1995
- Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice.Proceedings of the National Academy of Sciences, 1993
- Mitogenic properties of a new endothelial cell growth factor related to pleiotrophinBiochemical and Biophysical Research Communications, 1991